Eisele Jeffrey
Related Filers (1)
Other (8)
144
Tuesday, 1/30/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/29/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Monday, 1/22/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 1/17/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/16/2024
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/26/2023
Filing for proposed sale of securities under Rule 144
Ownership (21)
4
Wednesday, 1/31/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/24/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/23/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/18/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/17/2024
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/28/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/31/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/25/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/24/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/17/2023
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/23/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/1/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/25/2022
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/3/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/1/2021
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/23/2020
Apellis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 10/6/2020
Apellis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities